Secteur Medicenna Therapeutics Corp.

Actions

MDNA

CA58490H1073

Recherche biotechnologique et médicale

Marché Fermé - Toronto S.E. 18:41:50 21/07/2026 Varia. 5j. Varia. 1 janv.
0,3500 CAD 0,00% Graphique intraday de Medicenna Therapeutics Corp. -4,11% -61,96%
Principaux concurrents
Varia. Varia. 5j. Variation 1 mois Variation 3 mois Varia. 1 janv. Varia. 1an Varia. 3ans Varia. 5ans Varia. 10ans Capi.($)
0,00%-4,11%-18,60%-40,68%-61,96%-56,25%-37,50%-88,45% - 22,92 M
+1,80%-0,83%+23,10%+28,31%+39,51%+52,79%+86,50%-24,19% - 55,57 Md
-0,05%+1,23%-4,55%+12,00%+6,00%+56,05%+58,66%+179,85%+5 753,62% 54,26 Md
+0,18%+2,13%+1,58%-17,27%-3,01%-15,22%-14,97%-64,44% - 23,35 Md
+1,50%-1,35%+13,38%-22,95%-37,59%+5,68%+415,28%+317,45%+872,43% 23,54 Md
+0,05%-1,77%+26,35%+10,91%+23,54%+38,71%-4,22%-70,97% - 20,32 Md
+0,96%-1,40%+12,93%+5,29%-7,77%+34,98%-30,61%-33,21%+62,85% 17,36 Md
+1,08%-3,63%+31,75%+4,83%+31,82%+36,77%+547,87% - - 15,59 Md
0,00%-2,08%+22,96%+100,52%+177,32%+165,40%+297,92%+1 551,17%+605,57% 14,96 Md
+1,06%+0,63%+8,11%+22,29%+28,04%+26,80%+185,02%+229,54%+553,32% 14,11 Md
+2,07%+1,85%+8,11%+3,62%-6,10%+65,22%+153,44%+484,11% - 12,61 Md
+4,55%-4,44%+19,23%-33,76%-12,48%-32,72%+156,55%+84,51% - 11,11 Md
+2,53%-1,00%+2,96%+23,27%+27,65%+119,45%+147,89%+177,02%+714,36% 11,01 Md
+8,37%-5,43%+6,40%-44,54%-16,35%-44,46%+631,50%+91,24%+104,62% 11,36 Md
+4,01%+3,63%-8,92%+4,88%+12,25%+406,59%+106,54%+9,46%+1 235,48% 10,5 Md
+0,02%0,00%+0,43%+15,71%+23,23%+50,33%+177,13% - - 9,83 Md
+0,04%+0,23%+133,90%+115,68%+80,24%+171,08%+348,42%+324,81% - 8,85 Md
+0,70%-0,23%+28,54%-24,54%+19,17%+29,71%+93,03%-13,03% - 8,92 Md
+5,52%+3,79%+16,26%+44,10%+213,49%+528,13%+592,52%-40,12%-9,52% 9,03 Md
+4,38%+12,57%+56,47%+38,95%+27,70%+38,61%+372,13%+344,82% - 8,84 Md
Moyenne +1,94%-0,13%+19,02%+12,33%+28,23%+83,88%+214,15%+192,20%+1 099,19% 17,06 Md
Moyenne pondérée par Capi. +1,53%-0,57%+16,18%+13,66%+25,70%+68,87%+176,75%+172,23%+2 243,09%
Médicaments bio-thérapeutiques
  1. Bourse
  2. Actions
  3. Action MDNA
  4. Secteur Medicenna Therapeutics Corp.